The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Cachexia-Global Market Insights and Sales Trends 2024
Synopsis
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
The global Cancer Cachexia market size is expected to reach US$ 2220.1 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Cachexia in various end use industries. The expanding demands from the Hospital Stores, Retails Pharmacy Store and Online Pharmacy,, are propelling Cancer Cachexia market. Progestogens, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Corticosteroids segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cancer Cachexia market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Cachexia market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Cachexia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Cachexia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Cachexia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Cachexia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Cachexia covered in this report include Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis and Bristol-Myers Squibb, etc.
The global Cancer Cachexia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aeterna Zentaris
Alder BioPharmaceuticals
Aphios
Eli Lilly
GTx
Helsinn
Merck
Novartis
Bristol-Myers Squibb
XBiotech
Global Cancer Cachexia market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Cachexia market, Segment by Type:
Progestogens
Corticosteroids
Combination Therapies
Others
Global Cancer Cachexia market, by Application
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Cachexia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
The global Cancer Cachexia market size is expected to reach US$ 2220.1 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Cachexia in various end use industries. The expanding demands from the Hospital Stores, Retails Pharmacy Store and Online Pharmacy,, are propelling Cancer Cachexia market. Progestogens, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Corticosteroids segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cancer Cachexia market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Cachexia market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Cachexia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Cachexia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Cachexia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Cachexia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Cachexia covered in this report include Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis and Bristol-Myers Squibb, etc.
The global Cancer Cachexia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aeterna Zentaris
Alder BioPharmaceuticals
Aphios
Eli Lilly
GTx
Helsinn
Merck
Novartis
Bristol-Myers Squibb
XBiotech
Global Cancer Cachexia market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Cachexia market, Segment by Type:
Progestogens
Corticosteroids
Combination Therapies
Others
Global Cancer Cachexia market, by Application
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Cachexia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Cachexia
1.1 Cancer Cachexia Market Overview
1.1.1 Cancer Cachexia Product Scope
1.1.2 Cancer Cachexia Market Status and Outlook
1.2 Global Cancer Cachexia Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Cachexia Market Size by Region (2018-2029)
1.4 Global Cancer Cachexia Historic Market Size by Region (2018-2023)
1.5 Global Cancer Cachexia Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Cachexia Market Size (2018-2029)
1.6.1 North America Cancer Cachexia Market Size (2018-2029)
1.6.2 Europe Cancer Cachexia Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Cachexia Market Size (2018-2029)
1.6.4 Latin America Cancer Cachexia Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Cachexia Market Size (2018-2029)
2 Cancer Cachexia Market by Type
2.1 Introduction
2.1.1 Progestogens
2.1.2 Corticosteroids
2.1.3 Combination Therapies
2.1.4 Others
2.2 Global Cancer Cachexia Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Cachexia Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Cachexia Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Cachexia Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Cachexia Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Cachexia Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Cachexia Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Cachexia Revenue Breakdown by Type (2018-2029)
3 Cancer Cachexia Market Overview by Application
3.1 Introduction
3.1.1 Hospital Stores
3.1.2 Retails Pharmacy Store
3.1.3 Online Pharmacy
3.2 Global Cancer Cachexia Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Cachexia Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Cachexia Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Cachexia Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Cachexia Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Cachexia Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Cachexia Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Cachexia Revenue Breakdown by Application (2018-2029)
4 Cancer Cachexia Competition Analysis by Players
4.1 Global Cancer Cachexia Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Cachexia as of 2022)
4.3 Date of Key Players Enter into Cancer Cachexia Market
4.4 Global Top Players Cancer Cachexia Headquarters and Area Served
4.5 Key Players Cancer Cachexia Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Cachexia Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Aeterna Zentaris
5.1.1 Aeterna Zentaris Profile
5.1.2 Aeterna Zentaris Main Business
5.1.3 Aeterna Zentaris Cancer Cachexia Products, Services and Solutions
5.1.4 Aeterna Zentaris Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.1.5 Aeterna Zentaris Recent Developments
5.2 Alder BioPharmaceuticals
5.2.1 Alder BioPharmaceuticals Profile
5.2.2 Alder BioPharmaceuticals Main Business
5.2.3 Alder BioPharmaceuticals Cancer Cachexia Products, Services and Solutions
5.2.4 Alder BioPharmaceuticals Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.2.5 Alder BioPharmaceuticals Recent Developments
5.3 Aphios
5.3.1 Aphios Profile
5.3.2 Aphios Main Business
5.3.3 Aphios Cancer Cachexia Products, Services and Solutions
5.3.4 Aphios Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.3.5 Eli Lilly Recent Developments
5.4 Eli Lilly
5.4.1 Eli Lilly Profile
5.4.2 Eli Lilly Main Business
5.4.3 Eli Lilly Cancer Cachexia Products, Services and Solutions
5.4.4 Eli Lilly Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.4.5 Eli Lilly Recent Developments
5.5 GTx
5.5.1 GTx Profile
5.5.2 GTx Main Business
5.5.3 GTx Cancer Cachexia Products, Services and Solutions
5.5.4 GTx Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.5.5 GTx Recent Developments
5.6 Helsinn
5.6.1 Helsinn Profile
5.6.2 Helsinn Main Business
5.6.3 Helsinn Cancer Cachexia Products, Services and Solutions
5.6.4 Helsinn Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.6.5 Helsinn Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Cancer Cachexia Products, Services and Solutions
5.7.4 Merck Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Cancer Cachexia Products, Services and Solutions
5.8.4 Novartis Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Bristol-Myers Squibb
5.9.1 Bristol-Myers Squibb Profile
5.9.2 Bristol-Myers Squibb Main Business
5.9.3 Bristol-Myers Squibb Cancer Cachexia Products, Services and Solutions
5.9.4 Bristol-Myers Squibb Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.9.5 Bristol-Myers Squibb Recent Developments
5.10 XBiotech
5.10.1 XBiotech Profile
5.10.2 XBiotech Main Business
5.10.3 XBiotech Cancer Cachexia Products, Services and Solutions
5.10.4 XBiotech Cancer Cachexia Revenue (US$ Million) & (2018-2023)
5.10.5 XBiotech Recent Developments
6 North America
6.1 North America Cancer Cachexia Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Cachexia Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Cachexia Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Cachexia Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Cachexia Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Cachexia Market Dynamics
11.1 Cancer Cachexia Industry Trends
11.2 Cancer Cachexia Market Drivers
11.3 Cancer Cachexia Market Challenges
11.4 Cancer Cachexia Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
